CoChat

Fetal Brain mTOR Signaling Activation in Tuberous Sclerosis Complex

Open access
Tsai, Victoria, Parker, Whitney E., Orlova, Ksenia A., Baybis, Marianna, Chi, Anthony W.S., Berg, Benjamin D., Birnbaum, Jacqueline F., Estevez, Jacqueline, Okochi, Kei, Sarnat, Harvey B., Flores-Sarnat, Laura, Aronica, Eleonora, Crino, Peter B. · 2014 · Cerebral Cortex
Cited by 116

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

Abstract

Tuberous sclerosis complex (TSC) is characterized by developmental malformations of the cerebral cortex known as tubers, comprised of cells that exhibit enhanced mammalian target of rapamycin (mTOR) signaling. To date, there are no reports of mTORC1 and mTORC2 activation in fetal tubers or in neural progenitor cells lacking Tsc2. We demonstrate mTORC1 activation by immunohistochemical detection of substrates phospho-p70S6K1 (T389) and phospho-S6 (S235/236), and mTORC2 activation by substrates phospho-PKCα (S657), phospho-Akt (Ser473), and phospho-SGK1 (S422) in fetal tubers. Then, we show that Tsc2 shRNA knockdown (KD) in mouse neural progenitor cells (mNPCs) in vitro results in enhanced mTORC1 (phospho-S6, phospho-4E-BP1) and mTORC2 (phospho-Akt and phospho-NDRG1) signaling, as well as a doubling of cell size that is rescued by rapamycin, an mTORC1 inhibitor. Tsc2 KD in vivo in the fetal mouse brain by in utero electroporation causes disorganized cortical lamination and increased cell volume that is prevented with rapamycin. We demonstrate for the first time that mTORC1 and mTORC2 signaling is activated in fetal tubers and in mNPCs following Tsc2 KD. These results suggest that inhibition of mTOR pathway signaling during embryogenesis could prevent abnormal brain development in TSC.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/cercor/bhs310

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 10 references

Research works printed but not linked: 44

  1. Anderl, 2011, Therapeutic value of prenatal rapamycin treatment in a mouse brain model of tuberous sclerosis complex, Hum Mol Genet, 20, 4597, 10.1093/hmg/ddr393 · DOI · Paper page
  2. Arlotta, 2005, Neuronal subtype-specific genes that control corticospinal motor neuron development in vivo, Neuron, 45, 207, 10.1016/j.neuron.2004.12.036 · DOI · Paper page
  3. Bai, 2003, RNAi reveals doublecortin is required for radial migration in rat neocortex, Nat Neurosci, 6, 1277, 10.1038/nn1153 · DOI · Paper page
  4. Bissler, 2008, Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosis, N Engl J Med, 358, 140, 10.1056/NEJMoa063564 · DOI · Paper page
  5. Chen, 2005, Fezl regulates the differentiation and axon targeting of layer 5 subcortical projection neurons in cerebral cortex, Proc Natl Acad Sci USA, 102, 17184, 10.1073/pnas.0508732102 · DOI · Paper page
  6. Chen, 2010, Prenatal diagnosis of rhabdomyomas and cerebral tuberous sclerosis by magnetic resonance imaging in one fetus of a dizygotic twin pregnancy associated with a frameshift mutation in the TSC2 gene, Taiwan J Obstet Gynecol, 49, 387, 10.1016/S1028-4559(10)60083-6 · doi:10.1016/s1028-4559(10)60083-6
  7. Crino, 2010, The pathophysiology of tuberous sclerosis complex, Epilepsia, 51, 27, 10.1111/j.1528-1167.2009.02438.x · DOI
  8. Cubelos, 2010, Cux1 and Cux2 regulate dendritic branching, spine morphology, and synapses of the upper layer neurons of the cortex, Neuron, 66, 523, 10.1016/j.neuron.2010.04.038 · DOI · Paper page
  9. DiMario, 2004, Brain abnormalities in tuberous sclerosis complex, J Child Neurol, 19, 650, 10.1177/08830738040190090401 · DOI · Paper page
  10. Ess, 2012, New therapies for tuber-less sclerosis: white matter matters?, Neurology, 78, 520, 10.1212/WNL.0b013e318248a232 · DOI
  11. Feliciano, 2011, Single-cell Tsc1 knockout during corticogenesis generates tuber-like lesions and reduces seizure threshold in mice, J Clin Invest, 121, 1596, 10.1172/JCI44909 · DOI · Paper page
  12. Goto, 2011, Regulable neural progenitor-specific Tsc1 loss yields giant cells with organellar dysfunction in a model of tuberous sclerosis complex, Proc Natl Acad Sci USA, 108, E1070, 10.1073/pnas.1106454108 · DOI · Paper page
  13. Huang, 2008, The TSC1-TSC2 complex is required for proper activation of mTOR complex 2, Mol Cell Biol, 28, 4104, 10.1128/MCB.00289-08 · DOI · Paper page
  14. Huang, 2009, Signaling events downstream of mammalian target of rapamycin complex 2 are attenuated in cells and tumors deficient for the tuberous sclerosis complex tumor suppressors, Cancer Res, 69, 6107, 10.1158/0008-5472.CAN-09-0975 · DOI · Paper page
  15. Jambaque, 1991, Neuropsychological aspects of tuberous sclerosis in relation to epilepsy and MRI findings, Dev Med Child Neurol, 33, 698, 10.1111/j.1469-8749.1991.tb14947.x · DOI · Paper page
  16. Krueger, 2010, Everolimus for subependymal giant-cell astrocytomas in tuberous sclerosis, N Engl J Med, 363, 1801, 10.1056/NEJMoa1001671 · DOI · Paper page
  17. Kwon, 2003, mTor is required for hypertrophy of Pten-deficient neuronal soma in vivo, Proc Natl Acad Sci USA, 100, 12923, 10.1073/pnas.2132711100 · DOI · Paper page
  18. Kyin, 2001, Differential cellular expression of neurotrophins in cortical tubers of the tuberous sclerosis complex, Am J Pathol, 159, 1541, 10.1016/S0002-9440(10)62539-4 · DOI
  19. Levine, 1999, Central nervous system abnormalities assessed with prenatal magnetic resonance imaging, Obstet Gynecol, 94, 1011
  20. Magnitsky, 2008, Magnetic resonance imaging detects differences in migration between primary and immortalized neural stem cells, Acad Radiol, 15, 1269, 10.1016/j.acra.2008.05.003 · DOI
  21. Marcotte, 2012, Cytoarchitectural alterations are widespread in cerebral cortex in tuberous sclerosis complex, Acta Neuropathol, 123, 685, 10.1007/s00401-012-0950-3 · DOI
  22. Marcotte, 2006, The neurobiology of the tuberous sclerosis complex, Neuromol Med, 8, 531, 10.1385/NMM:8:4:531 · DOI
  23. Meikle, 2008, Response of a neuronal model of tuberous sclerosis to mammalian target of rapamycin (mTOR) inhibitors: effects on mTORC1 and Akt signaling lead to improved survival and function, J Neurosci, 28, 5422, 10.1523/JNEUROSCI.0955-08.2008 · DOI · Paper page
  24. Molyneaux, 2005, Fezl is required for the birth and specification of corticospinal motor neurons, Neuron, 47, 817, 10.1016/j.neuron.2005.08.030 · DOI · Paper page
  25. Nguyen, 2006, p27kip1 independently promotes neuronal differentiation and migration in the cerebral cortex, Genes Dev, 20, 1511, 10.1101/gad.377106 · DOI · Paper page
  26. Nieto, 2004, Expression of Cux-1 and Cux-2 in the subventricular zone and upper layers II-IV of the cerebral cortex, J Comp Neurol, 479, 168, 10.1002/cne.20322 · DOI · Paper page
  27. Orlova, 2010, STRADalpha deficiency results in aberrant mTORC1 signaling during corticogenesis in humans and mice, J Clin Invest, 120, 1591, 10.1172/JCI41592 · DOI · Paper page
  28. Orlova, 2010, Early progenitor cell marker expression distinguishes type II from type I focal cortical dysplasias, J Neuropathol Exp Neurol, 69, 850, 10.1097/NEN.0b013e3181eac1f5 · DOI · Paper page
  29. Park, 1997, Tuberous sclerosis in a 20-week gestation fetus: immunohistochemical study, Acta Neuropathol, 94, 180, 10.1007/s004010050691 · DOI
  30. Parker, 2011, Enhanced epidermal growth factor, hepatocyte growth factor, and vascular endothelial growth factor expression in tuberous sclerosis complex, Am J Pathol, 178, 296, 10.1016/j.ajpath.2010.11.031 · DOI
  31. Ruegg, 2007, Effects of rapamycin on gene expression, morphology, and electrophysiological properties of rat hippocampal neurons, Epilepsy Res, 77, 85, 10.1016/j.eplepsyres.2007.09.009 · DOI
  32. Saito, 2006, In vivo electroporation in the embryonic mouse central nervous system, Nat Protoc, 1, 1552, 10.1038/nprot.2006.276 · DOI · Paper page
  33. Samuel-Abraham, 2010, Staying on message: design principles for controlling nonspecific responses to siRNA, FEBS J, 277, 4828, 10.1111/j.1742-4658.2010.07905.x · DOI
  34. Sparagana, 2000, Tuberous sclerosis complex, Curr Opin Neurol, 13, 115, 10.1097/00019052-200004000-00001 · DOI · Paper page
  35. Tanaka, 2011, Oncogenic EGFR signaling activates an mTORC2-NF-kappaB pathway that promotes chemotherapy resistance, Cancer Discov, 1, 524, 10.1158/2159-8290.CD-11-0124 · DOI · Paper page
  36. Tillema, 2012, Everolimus alters white matter diffusion in tuberous sclerosis complex, Neurology, 78, 526, 10.1212/WNL.0b013e318247ca8d · DOI · Paper page
  37. Wang, 2007, Neocortical hyperexcitability in a human case of tuberous sclerosis complex and mice lacking neuronal expression of TSC1, Ann Neurol, 61, 139, 10.1002/ana.21058 · DOI · Paper page
  38. Way, 2009, Loss of Tsc2 in radial glia models the brain pathology of tuberous sclerosis complex in the mouse, Hum Mol Genet, 18, 1252, 10.1093/hmg/ddp025 · DOI · Paper page
  39. Way, 2012, The differential effects of prenatal and/or postnatal rapamycin on neurodevelopmental defects and cognition in a neuroglial mouse model of tuberous sclerosis complex, Hum Mol Genet, 21, 3226, 10.1093/hmg/dds156 · DOI · Paper page
  40. Wullschleger, 2006, TOR signaling in growth and metabolism, Cell, 124, 471, 10.1016/j.cell.2006.01.016 · DOI · Paper page
  41. Yang, 2006, TSC1/TSC2 and Rheb have different effects on TORC1 and TORC2 activity, Proc Natl Acad Sci USA, 103, 6811, 10.1073/pnas.0602282103 · DOI · Paper page
  42. Zaroff, 2006, Mental retardation and relation to seizure and tuber burden in tuberous sclerosis complex, Seizure, 15, 558, 10.1016/j.seizure.2006.06.010 · DOI
  43. Zeng, 2010, Regulation of cell death and epileptogenesis by the mammalian target of rapamycin (mTOR): a double-edged sword?, Cell Cycle., 9, 2281, 10.4161/cc.9.12.11866 · DOI
  44. Zeng, 2011, Tsc2 gene inactivation causes a more severe epilepsy phenotype than Tsc1 inactivation in a mouse model of tuberous sclerosis complex, Hum Mol Genet, 20, 445, 10.1093/hmg/ddq491 · DOI · Paper page

Cited by

See all 116

Metadata

Authors
Tsai, V., Parker, W. E., Orlova, K. A., Baybis, M., Chi, A. W. S., Berg, B. D., Birnbaum, J. F., Estevez, J., Okochi, K., Sarnat, H. B., Flores-Sarnat, L., Aronica, E., & Crino, P. B.
Venue
Cerebral Cortex
Published
2012-10-18
Volume
24
Issue
2
Pages
315-327
ISSN
  • 1047-3211 (ISSN-L)
  • 1460-2199
OpenAlex
W2169878097
Cited by
116
References
10
FWCI
6.98
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Fetal Brain mTOR Signaling Activation in Tuberous Sclerosis Complex. https://app.cochat.ai/papers/10.1093/cercor/bhs310
The paper
Tsai, V., Parker, W. E., Orlova, K. A., Baybis, M., Chi, A. W. S., Berg, B. D., Birnbaum, J. F., Estevez, J., Okochi, K., Sarnat, H. B., Flores-Sarnat, L., Aronica, E., & Crino, P. B. (2014). Fetal Brain mTOR Signaling Activation in Tuberous Sclerosis Complex. Cerebral Cortex. https://doi.org/10.1093/cercor/bhs310

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.